Table 3.
Unadjusted and adjusted rotavirus vaccine effectiveness in preventing hospitalizations due to rotavirus gastroenteritis by vaccine brand and number of doses received
| Confirmed and probable hospitalized rotavirus cases | Confirmed hospitalized rotavirus cases | |||||
|---|---|---|---|---|---|---|
| Vaccination status | Cases | VE (95% CI), % | Cases | VE (95% CI), % | ||
| Unadjusted | Adjusted | Unadjusted | Adjusted | |||
| Fully vaccinated | ||||||
| RV1 | 22 | 87(81–92) | 86(78–91) | 20 | 86(78–91) | 84(75–90) |
| RV5 | 20 | 89(82–93) | 88(81–92) | 12 | 91(85–95) | 91(84–95) |
| RV1 a | 22 | 87(80–91) | 85(77–90) | 20 | 85(77–91) | 84(74–90) |
| RV5 a | 19 | 88(80–92) | 87(80–92) | 11 | 91(84–95) | 91(83–95) |
| Partially vaccinated | ||||||
| RV1 (1 dose) | 6 | 84(65–93) | 82(60–92) | 3 | 90(69–97) | 89(66–97) |
| RV5 (2 doses) | 6 | 90(77–95) | 89(75–95) | 5 | 89(74–96) | 89(73–95) |
| RV5 (1 dose) | 9 | 83(68–91) | 83(66–91) | 7 | 84(65–92) | 84(66–92) |
| Unvaccinated | ||||||
| 768 | - | - | 616 | - | - | |
aChildren fulfilling the product information criteria for timing of vaccination.